NEETBiologyBiotechnology and Its ApplicationsMCQ+4 / −1
In gene therapy of Adenosine Deaminase (ADA) deficiency, the patient requires periodic infusion of genetically engineered lymphocytes because:
- ARetroviral vector is introduced into these lymphocytes.
- BGene isolated from marrow cells producing ADA is introduced into cells at embryonic stages
- CLymphocytes from patient's blood are grown in culture, outside the body
- DGenetically engineered lymphocytes are not immortal cells.
More from Biotechnology and Its Applications
- Statements related to human Insulin are given below. Which statements is/are correct about genetically engineered Insulin? (a) Pro-hormone insulin contain extra stretch of C-peptide (b) A-peptide and B-peptide chains of insulin were…2022 · MCQ
- When gene targetting involving gene amplification is attempted in an individual's tissue to treat disease, it is known as :2021 · MCQ
- With regard to insulin choose correct options. (1) C-peptide is not present in mature insulin. (2) The insulin produced by rDNA technology has C-peptide. (3) The pro-insulin has C-peptide (4) A-peptide and B-peptide of insulin are…2021 · MCQ
- Which of the following statements is not correct?2020 · MCQ
- Match the following columns and select the correct option. Includes table2020 · MCQ
- Which of the following glucose transporters is insulin-dependent?2019 · MCQ
- In India, the organisation responsible for assessing the safety of introducing genetically modified organisms for public use is2018 · MCQ
- Which of the following is commonly used as a vector for introducing a DNA fragment in human lymphocytes?2018 · MCQ